The idea of conducting tests for an infectious disease on the kitchen table would have seemed unimaginable only three years ago; now, it is a routine part of life in the UK. Similarly, measuring health markers such as heart rate or blood pressure used to involve a trip to your GP's surgery; now, they are measured by your watch.  Routine testing of cellular function may be the next step, supplying data on cellular changes that occur before the presentation of symptoms or rapidly assessing the efficacy of therapies.  Platelets play a vital role in chronic and acute cardiovascular disease but also have roles in immunity, inflammation, cancer metastasis, Alzheimer's disease and infections, such as dengue, HIV-1, malaria, and COVID-19.  In addition, they are easily obtained from subjects or patients, making them valuable biomarkers for changes in blood vessels associated with disease, ageing or therapy. This seminar will introduce the utility of platelets as a cellular biomarker and the progress we have made in designing tests that capture the function of these cells, both in the lab and at point-of-care.

Zimmer and Peacock has worked on the development and manufacture of a platform intended to translate academic blood testing assays from the lab into the clinical setting, and onto the market. At ZP, for research to be impactful and sustainable, it does need to be presented in a form factor so that it can be easily used by clinicians and patients. In this webinar and live streaming demo, ZP will show how a scientific paper can easily become a clinical product. The policy at ZP is to translate science into regulatory approved products in 2 years or less.